Fatty liver is an increasingly common disease that can progress toward more severe forms, involving inflammation, fibrosis, ...

A specific protein controls mRNA transport in fungi and distinguishes important from unimportant binding sites in the ...

Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and ...

Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...

OpenAI CEO Sam Altman recently described one of his most fascinating meetings: with Paul Conyngham, who used AI to develop a ...

Researchers at the University of Chicago Medicine have developed a lipid nanoparticle system capable of delivering mRNA to insulin-producing beta cells, delaying progression of Type 1 diabetes. In ...

In early-stage drug discovery, library size matters because biology is sparse. For most targets, only a tiny fraction of chemical space will bind at all, and an even smaller fraction will bind with ...

Today, Latent Labs announces Latent-X2, a frontier AI model that can design drug-like biologics without iteration. Drug hunters can use Latent Lab's AI platform, built on Latent-X2, to access ...

A NOVEL heart failure test using saliva instead of blood could transform how doctors detect and monitor the condition. Researchers in Australia have developed a biosensor capable of identifying a key ...